NASDAQ:BMRN
BioMarin
- Stock
Last Close
51.84
06/11 21:01
Market Cap
15.63B
Beta: 0.38
Volume Today
1.38M
Avg: 1.37M
PE Ratio
112.42
PFCF: 528.69
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 181.03M - | 235.57M 30.13% | 313.40M 33.04% | 415.45M 32.56% | 503.32M 21.15% | 605.57M 20.31% | 689.41M 13.84% | 737.61M 6.99% | 835.38M 13.25% | ||
average payables | 165.52M - | 314.13M 89.78% | 381.51M 21.45% | 386.21M 1.23% | 419.61M 8.65% | 503.96M 20.10% | 381.02M 24.39% | 192.22M 49.55% | 212.12M 10.36% | ||
average receivables | 131.15M - | 154.72M 17.97% | 190.12M 22.88% | 238.32M 25.35% | 302.00M 26.72% | 360.02M 19.21% | 412.88M 14.68% | 410.88M 0.49% | 417.36M 1.58% | ||
book value per share | 10.44 - | 15.00 43.71% | 16.67 11.08% | 16.10 3.38% | 16.76 4.10% | 17.44 4.04% | 22.71 30.22% | 23.36 2.85% | 24.85 6.38% | ||
capex per share | -0.81 - | -1.42 75.20% | -0.89 37.16% | -1.14 27.76% | -0.82 28.49% | -0.91 11.74% | -0.76 16.66% | -0.65 14.27% | -0.71 8.89% | -0.50 28.92% | |
capex to depreciation | -2.09 - | -4.82 130.37% | -1.53 68.26% | -2.27 48.09% | -1.51 33.33% | -1.55 2.66% | -1.31 15.74% | -1.10 15.60% | -1.29 16.90% | -1.02 21.23% | |
capex to operating cash flow | 1.62 - | 1.03 36.45% | 0.65 36.58% | 22.75 3,393.21% | -7.16 131.46% | -3.39 52.69% | -1.61 52.42% | -0.39 75.70% | -0.75 91.01% | -0.61 18.81% | |
capex to revenue | -0.16 - | -0.26 61.68% | -0.13 48.07% | -0.15 14.15% | -0.10 36.05% | -0.10 1.12% | -0.07 22.92% | -0.06 12.64% | -0.06 2.82% | -0.04 36.31% | |
cash per share | 6.46 - | 3.70 42.66% | 4.76 28.47% | 8.00 68.22% | 6.12 23.48% | 4.21 31.25% | 5.89 39.95% | 5.54 5.90% | 6.97 25.73% | ||
days of inventory on hand | 561.02 - | 652.36 16.28% | 618.36 5.21% | 718.23 16.15% | 614.62 14.43% | 690.75 12.39% | 486.33 29.59% | 602.50 23.89% | 674.72 11.99% | ||
days payables outstanding | 663.09 - | 942.49 42.14% | 645.14 31.55% | 606.74 5.95% | 506.28 16.56% | 579.41 14.44% | 133.27 77.00% | 149.72 12.34% | 174.50 16.55% | ||
days sales outstanding | 70.21 - | 67.66 3.64% | 70.36 3.98% | 72.62 3.22% | 83.87 15.48% | 80.84 3.61% | 87.96 8.81% | 73.82 16.08% | 80.33 8.82% | ||
debt to assets | 0.26 - | 0.18 32.78% | 0.17 4.38% | 0.25 49.29% | 0.19 26.00% | 0.18 3.59% | 0.19 2.78% | 0.18 2.35% | 0.17 5.50% | ||
debt to equity | 0.43 - | 0.28 35.94% | 0.25 10.46% | 0.42 69.30% | 0.28 33.09% | 0.27 2.92% | 0.26 2.55% | 0.26 3.62% | 0.24 6.89% | ||
dividend yield | |||||||||||
earnings yield | -0.01 - | -0.01 1.20% | -0.05 347.24% | -0.01 83.58% | -0.01 31.94% | -0.00 69.24% | 0.05 3,539.50% | -0.00 107.32% | 0.01 286.14% | 0.01 22.91% | |
enterprise value | 13.01B - | 17.03B 30.87% | 14.03B 17.64% | 16.13B 15.01% | 15.41B 4.44% | 15.55B 0.88% | 16.28B 4.71% | 16.65B 2.25% | 19.53B 17.33% | ||
enterprise value over ebitda | -94.46 - | -59.28 37.24% | -72.88 22.95% | -224.98 208.68% | -153.75 31.66% | -699.03 354.66% | -2.78K 298.13% | 346.62 112.45% | 122.44 64.67% | ||
ev to operating cash flow | -176.95 - | -76.82 56.59% | -61.56 19.86% | -1.84K 2,892.26% | 762.73 141.41% | 322.17 57.76% | 190.72 40.80% | 54.66 71.34% | 111.04 103.13% | ||
ev to sales | 17.33 - | 19.14 10.45% | 12.56 34.38% | 12.28 2.22% | 10.34 15.82% | 9.12 11.72% | 8.75 4.09% | 9.02 3.03% | 9.32 3.35% | ||
free cash flow per share | -1.31 - | -2.81 113.62% | -2.27 19.28% | -1.19 47.39% | -0.70 41.07% | -0.64 8.47% | -0.29 55.15% | 1.01 451.34% | 0.24 76.37% | 0.33 36.38% | |
free cash flow yield | -0.01 - | -0.03 84.33% | -0.03 2.08% | -0.01 51.13% | -0.01 38.29% | -0.01 7.82% | -0.00 56.75% | 0.01 448.71% | 0.00 79.83% | 0.00 46.38% | |
graham net net | 1.30 - | -2.98 328.42% | -0.78 73.95% | 0.03 104.01% | 0.83 2,582.83% | -1.06 227.81% | 0.05 104.63% | -0.28 658.80% | 1.69 713.15% | ||
graham number | 14.66 - | 19.04 29.82% | 37.73 98.21% | 15.59 58.68% | 12.82 17.75% | 7.23 43.63% | 49.27 581.56% | 13.57 72.46% | 20.67 52.30% | ||
income quality | 0.55 - | 1.29 135.08% | 0.36 71.98% | 0.07 79.30% | -0.26 449.81% | -2.02 673.23% | 0.10 104.91% | -4.75 4,882.78% | 1.24 126.15% | 0.95 23.55% | |
intangibles to total assets | 0.08 - | 0.24 179.06% | 0.19 21.01% | 0.15 17.35% | 0.16 0.89% | 0.14 10.43% | 0.10 24.73% | 0.10 7.13% | 0.08 13.90% | 0 100% | |
interest coverage | -2.54 - | -2.89 14.18% | -20.34 602.70% | -0.34 98.31% | -2.83 721.88% | -5.35 89.03% | -3.28 38.58% | -3.91 19.14% | 3.60 192.09% | -9.12 353.10% | |
interest debt per share | 4.75 - | 4.38 7.77% | 4.35 0.53% | 6.98 60.26% | 4.94 29.26% | 4.87 1.39% | 6.17 26.82% | 6.04 2.12% | 5.99 0.90% | ||
inventory turnover | 0.65 - | 0.56 14.00% | 0.59 5.50% | 0.51 13.90% | 0.59 16.86% | 0.53 11.02% | 0.75 42.03% | 0.61 19.28% | 0.54 10.70% | ||
invested capital | 0.43 - | 0.28 35.94% | 0.25 10.46% | 0.42 69.30% | 0.28 33.09% | 0.27 2.92% | 0.26 2.55% | 0.26 3.62% | 0.24 6.89% | ||
market cap | 13.23B - | 16.76B 26.71% | 13.75B 17.98% | 15.55B 13.12% | 15.08B 3.07% | 15.14B 0.40% | 15.85B 4.74% | 16.15B 1.89% | 19.17B 18.68% | 18.47T 96,251.21% | |
net current asset value | 463.07M - | -238.88M 151.59% | 164.38M 168.81% | 382.68M 132.81% | 597.03M 56.01% | 374.49M 37.28% | 600.20M 60.27% | 541.80M 9.73% | 979.54M 80.79% | ||
net debt to ebitda | 1.58 - | -0.92 158.48% | -1.43 54.73% | -8.04 462.79% | -3.36 58.26% | -18.46 450.16% | -72.82 294.40% | 10.24 114.06% | 2.25 78.05% | ||
net income per share | -0.92 - | -1.07 17.28% | -3.80 253.66% | -0.67 82.33% | -0.44 35.01% | -0.13 69.45% | 4.75 3,667.23% | -0.35 107.38% | 0.76 318.03% | 0.87 14.51% | |
operating cash flow per share | -0.50 - | -1.39 175.69% | -1.37 0.92% | -0.05 96.34% | 0.11 327.33% | 0.27 136.19% | 0.47 75.15% | 1.67 252.75% | 0.95 42.99% | 0.83 12.45% | |
payables turnover | 0.55 - | 0.39 29.65% | 0.57 46.09% | 0.60 6.33% | 0.72 19.84% | 0.63 12.62% | 2.74 334.75% | 2.44 10.99% | 2.09 14.20% | ||
receivables turnover | 5.20 - | 5.39 3.77% | 5.19 3.83% | 5.03 3.12% | 4.35 13.41% | 4.52 3.74% | 4.15 8.10% | 4.94 19.16% | 4.54 8.11% | ||
research and ddevelopement to revenue | 0.61 - | 0.71 16.08% | 0.59 16.92% | 0.46 21.55% | 0.47 0.44% | 0.42 10.14% | 0.34 19.54% | 0.34 0.88% | 0.31 9.00% | 0.31 0.40% | |
return on tangible assets | -0.06 - | -0.06 2.63% | -0.19 219.25% | -0.03 84.49% | -0.02 30.85% | -0.01 71.39% | 0.16 2,877.85% | -0.01 107.21% | 0.02 304.96% | ||
revenue per share | 5.13 - | 5.56 8.36% | 6.73 21.00% | 7.53 11.93% | 8.42 11.83% | 9.52 13.01% | 10.29 8.11% | 10.10 1.87% | 11.31 12.05% | 12.63 11.61% | |
roe | -0.09 - | -0.07 18.39% | -0.23 218.37% | -0.04 81.71% | -0.03 37.57% | -0.01 70.64% | 0.21 2,839.42% | -0.02 107.17% | 0.03 304.96% | ||
roic | -0.05 - | -0.04 11.99% | -0.18 340.14% | -0.01 93.18% | -0.02 46.13% | -0.01 54.95% | 0.38 4,836.50% | -0.01 102.53% | 0.01 200.43% | ||
sales general and administrative to revenue | 0.40 - | 0.45 12.36% | 0.43 5.60% | 0.42 1.11% | 0.41 3.96% | 0.18 - | 0.19 6.80% | 0.19 0.37% | |||
shareholders equity per share | 10.44 - | 15.00 43.71% | 16.67 11.08% | 16.10 3.38% | 16.76 4.10% | 17.44 4.04% | 22.71 30.22% | 23.36 2.85% | 24.85 6.38% | ||
stock based compensation to revenue | 0.12 - | 0.13 6.68% | 0.12 3.81% | 0.11 11.43% | 0.10 6.53% | 0.09 5.99% | 0.10 8.69% | 0.11 4.78% | 0.09 12.34% | 0.09 8.60% | |
tangible asset value | 1.32B - | 1.52B 15.39% | 2.02B 32.61% | 2.09B 3.90% | 2.28B 8.83% | 2.47B 8.32% | 3.49B 41.47% | 3.69B 5.54% | 4.07B 10.38% | ||
tangible book value per share | 9.00 - | 9.50 5.53% | 12.14 27.85% | 12.01 1.13% | 12.87 7.21% | 13.79 7.13% | 19.32 40.09% | 20.16 4.35% | 21.96 8.94% | ||
working capital | 1.19B - | 644.18M 45.86% | 982.48M 52.52% | 1.39B 41.54% | 1.53B 10.24% | 1.01B 34.14% | 1.85B 83.20% | 1.73B 6.22% | 2.16B 24.68% |
All numbers in USD (except ratios and percentages)